Key Metrics
Price Performance
30-DAY PRICE CHART
1-YEAR PERFORMANCE
Decision Support
What Matters Now
- The read on the stock is often driven by pipeline durability, reimbursement pressure, and whether new launches can offset patent cliffs.
- UNH trades at 28.8x earnings, well above the healthcare average of 22.0x, so the market is already pricing in above-consensus execution.
- UNH carries a beta of 0.65, which means the stock should be judged on how it affects total portfolio swings, not just on standalone upside.
- Relative performance versus JNJ, PFE, ABBV matters here because leadership inside healthcare rarely stays static for long.
Portfolio Use Case
- UNH is more relevant for investors who want some income support alongside price appreciation, not just pure growth exposure.
- The beta profile suggests it can fit a quality or lower-volatility sleeve more naturally than a high-octane tactical basket.
- The stock becomes more useful when paired with an explicit catalyst watchlist, because sector sentiment can shift quickly around policy, rates, or pipeline news.
What Would Change the View
- A reset in earnings expectations or a faster peer catch-up could compress the premium valuation currently embedded in UNH.
- Volatility is already above the sector norm, so even a correct long-term thesis can be painful if the position size is too aggressive.
- The view would need revisiting if peers such as JNJ, PFE, ABBV start winning the marginal flow or posting cleaner operating momentum.
Methodology
- Price, market cap, beta, yield, and liquidity fields for UNH come from Yahoo Finance quote and summary data.
- 30-day volatility is calculated from recent daily returns and annualized using a 252-trading-day convention.
- Sector context uses stored benchmark averages for Healthcare so each page compares the ticker against a stable peer baseline rather than against the whole market.
- Peer comparisons use the Portfolio Terminal coverage set and highlight nearby listed alternatives such as JNJ, PFE, ABBV.
Sources
Live quote, valuation, beta, yield, and volume fields used for UNH. Last refresh: May 29, 2026, 9:52 AM.
Explains how analytics, refresh cadence, and portfolio interpretation work across the product.
Comparative context for this page is anchored around nearby tracked names such as JNJ, PFE, ABBV.
Editorial note
Written by Portfolio Terminal Research. Template updated 3/24/2026, with market data refreshed from the latest feed on 5/29/2026, 9:52:51 AM. This page is designed for research workflow and portfolio monitoring, not personalized investment advice.
Healthcare Sector Context
Competitors Analysis
Technical Analysis
UnitedHealth Group is currently trading at $382.53, which is 5.3% below its 52-week high. With a beta of 0.65, the stock shows lower sensitivity to market movements.
Frequently Asked Questions
Is UNH a good buy right now?
UnitedHealth Group trades at 28.8x earnings. This is near market average. Current risk level is Medium based on 23.5% volatility.
Does UNH pay dividends?
Yes, UnitedHealth Group offers a dividend yield of 2.31%. This translates to approximately $8.84 per share annually.
How volatile is UNH?
With 30-day annualized volatility of 23.5% and beta of 0.65,UNH is classified as Medium risk. The stock tends to be more stable than the market average.
Related Assets
Track UNH Live
Add UnitedHealth Group to your Portfolio Terminal for real-time alerts and risk updates.
OPEN TERMINALIMPORT BROKER FILE